$39.94
-2.02-4.81%
At Close: -
$39.94
00.00%
After Hours: 5:03 PM EDT
15 minutes delayed
Neurogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Neurogene using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-1.09 | $-1.05 | -3.81 % |
Mar 2024 | 2024-05-10 | $-1.00 | $-1.13 | 11.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Neurogene (NGNE) is scheduled to report earnings on November 15, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-1.09, which missed the estimate of $-1.05.
The Actual Revenue was $925K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.